Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
1 hedge funds and large institutions have $897 invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0.03% less ownership
Funds ownership: 0.03% → 0.01% (-0.03%)
67% less funds holding
Funds holding: 3 → 1 (-2)
68% less capital invested
Capital invested by funds: $2.8K → $897 (-$1.9K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Cutler Group
San Francisco,
California
|
-$2K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8 |
PILL Hedge Fund Activity: Q3 2023 in Review
1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q3 2023, worth a combined $897 — down 68% from $2.8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PILL and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Cutler Group, exiting entirely with an estimated $2K sold.
- 1 institutional investor held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q3 2023, down from 3 in Q2 2023.
- Funds reported $897 of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q3 2023, down 68% quarter-over-quarter.
- 0 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q3 2023 and 2 closed out, a net change of -2 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q3 2023 was Cutler Group, an estimated $2K sold.
Based on aggregated 13F filings for Q3 2023.